Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02192255 · ClinicalTrials.gov registry record · NA
SUPREME-DM (Diabetes Mellitis) Treatment Study
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 2,378
- Enrollment target
NCT02192255: Completed NA study, sponsored by HealthPartners Institute.
NCT02192255 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 2,378 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02192255, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,378 participants
- Enrollment target
Study Summary
This multisite pragmatic clinical trial was designed to assess the effectiveness of a single scripted telephone call to diabetes patients who (a) were currently above recommended clinical goals for glucose, blood pressure, or lipids, and (b) had recently been prescribed a new medication for that specific clinical domain. The goals of the intervention were to improve primary adherence and persistence to the newly prescribed medication and to improve control of glucose, blood pressure, and lipids.
Primary Outcome
In a pragmatic randomized trial, we randomly assigned 2,378 adults with diabetes mellitus who were recently prescribed a new class of medication for elevated glycated hemoglobin (A1c) \>= 8%, blood pressure \>= 140/90 mm Hg, or low-density lipoprotein cholesterol \>=100 mg/dL, to receive (a) one scripted telephone call from a diabetes educator or clinical pharmacist to identify and address nonadherence to the new medication or (b) usual care. Hierarchical linear and logistic regression models we
Interventions
- BEHAVIORAL Intervention Phone Call
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,378 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT02192255 record still lists
NCT02192255 is an interventional study that assigns participants to a tested intervention. Its 2,378 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% higher).
The record links to 0 conditions, and to 1 intervention - of which Intervention Phone Call is the first listed.
NCT02192255 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02192255 about?
NCT02192255 is a clinical study titled "SUPREME-DM (Diabetes Mellitis) Treatment Study". This multisite pragmatic clinical trial was designed to assess the effectiveness of a single scripted telephone call to diabetes patients who (a) were currently above recommended clinical goals for glucose, blood pressure, or lipids, and (b) had recently been prescribed a new medication for that spe...
What is the current status of trial NCT02192255?
This trial is currently completed. It is a NA study. The enrollment target is 2,378 participants. The study started on 2012-01. Estimated completion is 2013-03.
What interventions are being tested in trial NCT02192255?
The interventions under investigation include: Intervention Phone Call (BEHAVIORAL).
Who is sponsoring clinical trial NCT02192255?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02192255's enrollment target sits among peer trials
2,378 46th of 2000 higher than 1,955 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05868421 · 2,376 participants · NA
Veteran Social Support for Enhancing Use of Smoking Cessation Treatment
- NCT06747494 · 2,396 participants · NA
General vs Spinal in Total Joint Arthroplasty (TJA)
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia